From Molecular Biology to Biotech Entrepreneurship: Pioneering Antimicrobial Therapies and Novel Drug Development in Infectious Disease | Jeffrey Stei ,CEO, Cidara Therapeutics Inc. 00:10:00
This interview delves into Dr. Jeffrey Stein's illustrious journey from a background in molecular biology to becoming a prominent figure in biotech entrepreneurship, focusing on the development of antimicrobial therapies and innovative drugs for combating infectious diseases. Through his experiences as CEO of Sidera Therapeutics, Dr. Stein discusses the evolution of his career, the challenges of developing novel treatments, and the groundbreaking potential of antiviral conjugates in revolutionizing infectious disease management.